|
Market Closed -
Borsa Istanbul
10:08:01 2026-11-16 EST
|
5-day change | 1st Jan Change | ||
| 75.15 TRY | -2.59% |
|
-6.65% | +19.86% |
| Market Cap | 15.03B 298M 271M 250M 226M 426M 28.01B 443M 3.01B 1.19B 1.12B 1.1B 47.53B | P/E 2024 |
226x | P/E 2025 | -15.5x |
|---|---|---|---|---|---|
| Enterprise Value | 17.42B 346M 314M 290M 262M 494M 32.46B 513M 3.49B 1.38B 1.3B 1.27B 55.08B | EV / Sales 2024 |
1.27x | EV / Sales 2025 | 0.78x |
| Free-Float |
17.78% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -2.59% | ||
| 1 week | -6.65% | ||
| Current month | +8.52% | ||
| 1 month | -3.78% | ||
| 3 months | +3.58% | ||
| 6 months | +12.58% | ||
| Current year | +19.86% |
| 1 week | 74.85 | 80.8 | |
| 1 month | 66.65 | 87.2 | |
| Current year | 57.5 | 109.3 | |
| 1 year | 57.5 | 109.3 | |
| 3 years | 51 | 109.3 | |
| 5 years | 24.3 | 109.3 | |
| 10 years | 3.08 | 109.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Philipp Haas
CEO | Chief Executive Officer | - | 2006-07-13 |
Alper Acindi
DFI | Director of Finance/CFO | - | 2025-10-31 |
Mesut Çetin
DFI | Director of Finance/CFO | 47 | 2008-03-13 |
| Director | Title | Age | Since |
|---|---|---|---|
Philipp Haas
CHM | Chairman | - | 2006-07-13 |
Aysecik Haas
BRD | Director/Board Member | - | 2013-05-21 |
Tuncay Cem Akkus
BRD | Director/Board Member | - | 2015-04-07 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.59% | -6.65% | +20.63% | -12.77% | 306M | ||
| -0.82% | +5.74% | +39.64% | +143.26% | 1,286B | ||
| -1.12% | +2.29% | +44.21% | +89.89% | 688B | ||
| -0.16% | +1.11% | +26.76% | +114.06% | 521B | ||
| +1.14% | +4.87% | +43.06% | +71.97% | 386B | ||
| -2.23% | -1.55% | +55.47% | +42.54% | 364B | ||
| +1.27% | +2.01% | +30.01% | +62.35% | 302B | ||
| +0.37% | +0.75% | +3.71% | +39.09% | 287B | ||
| -0.72% | +0.41% | +37.29% | +69.33% | 252B | ||
| -0.30% | +0.41% | +34.04% | +123.32% | 208B | ||
| Average | -0.39% | +1.45% | +33.48% | +74.30% | 429B | |
| Weighted average by Cap. | -0.40% | +3.26% | +36.97% | +98.26% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 15.46B 307M 279M 258M 233M 438M 28.8B 455M 3.09B 1.23B 1.15B 1.13B 48.88B | 19.25B 382M 347M 321M 290M 546M 35.86B 567M 3.85B 1.53B 1.43B 1.4B 60.85B |
| Net income | 69.42M 1.38M 1.25M 1.16M 1.04M 1.97M 129M 2.04M 13.9M 5.51M 5.17M 5.06M 219M | -807M -16.01M -14.56M -13.45M -12.14M -22.88M -1.5B -23.76M -162M -64.03M -60.06M -58.81M -2.55B |
| Net Debt | 4B 79.29M 72.07M 66.59M 60.12M 113M 7.45B 118M 800M 317M 297M 291M 12.63B | 2.39B 47.42M 43.11M 39.83M 35.96M 67.77M 4.45B 70.37M 478M 190M 178M 174M 7.56B |
Employees
3,079
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-16 | TRY 75.15 | -2.59% | 318,712 |
| 26-11-13 | TRY 77.15 | -1.47% | 268,004 |
| 26-11-12 | TRY 78.30 | +3.30% | 356,363 |
| 26-11-11 | TRY 75.80 | -2.57% | 366,508 |
| 26-11-10 | TRY 77.80 | -2.02% | 352,265 |
- Stock Market
- Stocks
- DEVA Stock
Select your edition
All financial news and data tailored to specific country editions
















